Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Eurofins CDMO Alphora | Contract Pharma

What are you searching for?

Sign in

Search by

Eurofins CDMO Alphora

Company Headquarters

2395 Speakman Dr., Suite 2001 , Mississauga, ON, L5K1B3, CA

Driving Directions Phone: View Phone Fax: View Fax
View website

Request more information from Eurofins CDMO Alphora

Request more information from Eurofins CDMO Alphora

Categories from Eurofins CDMO Alphora

Accelerated Stability Studies
Analytical Laboratory Services
Analytical Methods Development
Analytical Validation Studies
Assay Development
cGMP Synthesis
Chromatographic Analysis, LC/GC
Chromatography
CMC (Chemistry, Manfacturing & Controls)
Contract Development and Manufacturing Organization (CDMO)
Contract Manufacturing
Contract Research
Custom Synthesis
Forced Degradation Studies
Manufacturing, API

Related Content

Breaking News

Eurofins CDMO Alphora to Launch AI-Powered Software for High-Throughput Screening

High-throughput salt and co-crystal screening is now a core component of all solid-state screening programs.

By: Patrick Lavery

Breaking News

Eurofins CDMO Alphora to Construct New GMP Biologics Manufacturing Facility

The 50,000 sq ft facility in Mississauga, Ontario is scheduled for completion in April 2026.

Breaking News

Eurofins CDMO Alphora Completes New API Manufacturing Facility

The new API facility adds 15,000 sq.-ft. of GMP processing and warehousing space, expanding its capacity and capabilities.

Breaking News

Eurofins CDMO Alphora Launches Expanded Drug Product Analytical Laboratory

Increases its footprint three-fold.

Breaking News

Eurofins Alphora Completes Pilot Scale mAbs Development Facility

3,300 sq.-ft. facility dedicated to development and scaling of mAbs and other mammalian-based therapeutic proteins.

Breaking News

Eurofins CDMO Alphora Expands API Development Labs

Relocates and expands analytical services and research and development laboratories to new campus hosting all biopharmaceutical activities.

Breaking News

Eurofins Acquires Alphora Research

Expands role in biopharmaceutical services

Breaking News

Alphora Expands Lab Space

Completes new 3,000 sq. ft. analytical laboratory workspace

Breaking News

Alphora Completes GMP Kilo Lab

Supports Class 4 HPAPI’s

Breaking News

Alphora Completes R&D Cyto-Lab

Expands by 50%

Breaking News

Alphora Expands Operations

Alphora will further expand its facilities and capabilities for API technology development across all areas, with a focus on R&D, cGMP operations, and analytical services.

Breaking News

Alphora Expands Facilities for New Pilot Plant